Thermo Fisher Scientific (TMO) Other Operating Expenses (2009 - 2026)

Thermo Fisher Scientific has disclosed Other Operating Expenses across 18 years of filings, most recently posting $6.6 billion for Q1 2026.

• Quarterly Other Operating Expenses rose 7.28% year-over-year to $6.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.8 billion (up 6.35% YoY) and the FY2025 annual result came in at $26.6 billion, up 4.33% from the prior year.
• Other Operating Expenses fell to $6.6 billion in Q1 2026, from $7.2 billion in the prior quarter.
• Over five years, Other Operating Expenses peaked at $7.2 billion in Q4 2025 and troughed at $6.1 billion in Q1 2025.
• A 5-year average of $6.5 billion and a median of $6.4 billion in 2023 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 36.25% — and 2024, when it decreased 6.56%.
• Tracing TMO's Other Operating Expenses over 5 years: stood at $6.8 billion in 2022, then decreased by 5.13% to $6.5 billion in 2023, then climbed by 1.25% to $6.6 billion in 2024, then climbed by 9.61% to $7.2 billion in 2025, then dropped by 8.74% to $6.6 billion in 2026.
• Business Quant data shows TMO's Other Operating Expenses at $6.6 billion in Q1 2026, $7.2 billion in Q4 2025, and $6.5 billion in Q3 2025.